Please login to the form below

Not currently logged in
Email:
Password:

personalised medicines

This page shows the latest personalised medicines news and features for those working in and with pharma, biotech and healthcare.

Greater Manchester backs move to outcome-based payment

Greater Manchester backs move to outcome-based payment

able to access new and innovative medicines as early as possible and delivering better value for money.”. ... We’re set to see more personalised medicines being launched over the next few years, so additional data will help ensure those treatments

Latest news

  • CAR-Ts go head-to-head after NICE clears Kymriah in DLBCL CAR-Ts go head-to-head after NICE clears Kymriah in DLBCL

    Meindert Boysen, director of the Centre for Health Technology Evaluation at NICE said: “Recommending another revolutionary CAR T-cell therapy for adults with lymphoma represents a step forward for personalised medicine. ... Providing the latest cutting

  • Hancock says UK genome service is now ‘rolling out’ Hancock says UK genome service is now ‘rolling out’

    The news was welcomed by Mike Thompson, chief executive of the Association of the British Pharma Industry (ABPI), who said: “The health secretary’s focus on earlier diagnosis and more personalised ... medicines for cancer and rare diseases is great

  • Novartis cuts manufacturing jobs in Switzerland and UK Novartis cuts manufacturing jobs in Switzerland and UK

    Chief executive Vas Narasimhan says the cuts are part of Novartis’ strategy to move away from high-volume drug production towards more specialised and personalised medicines.

  • UK pharma to work with innovation network on NHS uptake UK pharma to work with innovation network on NHS uptake

    The UK pharma industry association the ABPI has announced a five-year deal with the AHSN Network aimed at encouraging a quicker, more consistent stream of  medicines and other 'biomedical innovations' ... These areas include economic growth, digital

  • GSK: we won’t be splitting up any time soon GSK: we won’t be splitting up any time soon

    prescription medicines businesses. ... GSK is investing $300m in the firm, and says a long-term partnership to exploit its genetic databases will help it advance personalised medicines research throughout its pipeline.

More from news
Approximately 13 fully matching, plus 54 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 4 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • 'Fake news': battling misinformation in healthcare

    As the pharmaceutical landscape becomes more complex and as personalised and precision medicines emerge, these stories are increasingly impacting patients and healthcare professionals.

  • Mastering the precision medicine opportunity

    Personalised: Developing and choosing medicines that will change the patient experience, from one of hope to one of certainty of response. ... In personalised medicine, we ask if we can use a particular treatment in a patient.

  • Medopad: the up and coming unicorn transforming remote patient monitoring

    The company has developed a platform for creating modular apps which can be personalised across numerous patient cohorts, using a combination of artificial intelligence, rich data analysis and a strong understanding ... Healthcare is becoming more precise

  • Medicines personalised for Tom, Dick and Harry

    And so enters the concept of personalised medicine with the aim of providing treatments to ever-shrinking populations of high responders. ... Perhaps more radical ideas need to be considered to deliver personalised medicine that is both equitable and

  • Being Human - The healthcare angle

    The industry is busily developing innovative, often personalised medicines, but we’re under unprecedented scrutiny.

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Playing Mind Games
To give a brief strong direction, we need to ascertain how the brand intends to win attention, how it will engage, what its call to action will be and how...
PM Society Digital Award Finalists
P&P are shortlisted for the ‘Craft in Film’ category at this year’s PM Society Digital Awards...
The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....

Infographics